Movement Alert|McKesson Intraday Rise 3.35% in Regular Trading, earnings beat and higher full-year outlook support shares

Market Focus11-05

On November 5, McKesson rose 3.35% in Regular Trading, trading at $1094.96/share, with turnover of $102 million.

The clearest catalyst was the company’s latest quarterly report and raised guidance, followed later by an analyst price-target increase.

McKesson reported fiscal Q2 adjusted EPS of $11.68, up from $9.86 a year earlier and above the $10.72 consensus, while revenue rose to $110.96 billion from $103.15 billion and exceeded the $109.90 billion expectation. The company also lifted its fiscal 2027 adjusted EPS outlook to $45.60-$46.40 from $44.20-$45.00, ahead of the $44.65 market view. Separately, Leerink Partners raised its price target to $1,200 from $1,070, above the broader analyst mean target of about $1,122.71. These updates reinforced positive sentiment after recent expansion moves, including the pending Option Care Health transaction.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment